Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Overcoming Resistance in HER2+ Metastatic Breast Cancer: Single Anti-HER2 and Dual HER2 Blockade Resistance

0 views
December 4, 2019
Comments 0
Login to view comments. Click here to Login